Merger and Acquisitions as of Nov 20th

Data brought to you by Benzinga APIs

Recent M&A News

Ricky Williams' Highsman Merges With Hemp Brand Frozen Fields

Highsman and Frozen Fields merge to form Top Seed Inc., aiming for national growth, innovation, and readiness for U.S. cannabis reforms.

OGroups Maja Vujinovic Says M&A Is Going To Increase; Says Not All Companies Are Going To Survive

S&P 500 To Reach 6,500 By End Of 2025, Analysts Predict: Could It Spark M&A Revival?

Wall Street analysts expect S&P 500 index to reach 6,500 points by 2025, driven by economic growth & earnings. Tech giants still leading but margins narrowing.

Amcor And Berry Seal The Deal: $73.59 Per Share Merger To Forge Packaging Powerhouse

Amcor and Berry agree to merge in all-stock transaction, with combined company valued at $24 billion, $4.3 billion EBITDA, and $3 billion cash flow.

Nippon Steel Execs Rally Support in Pennsylvania Amid Pushback On US Steel Takeover

Despite these political challenges, Nippon Steel is seeking regulatory approval post-election.

Chamath Palihapitiya Says Don't Expect 'Crazy M&A Deals' In 2025

He attributes this to the prevailing interest rates, which he argues are not conducive for companies that missed the opportunity to go public when rates were more favorable.

MakeMyTrip Agrees To Acquire Happay, Bolstering Its Arsenal For Corporate Travel Solutions

MakeMyTrip to acquire Happay Expense Management Platform from CRED, strengthening their position in corporate travel and expense management.

MCB Withdraws $15/Share Whitestone REIT Acquisition Proposal, Criticizes Board Entrenchment; Calls For Strategic Review To Maximize Shareholder Value

Dear Whitestone REIT Board of Trustees:MCB Real Estate ("MCB" or "we") delivered an attractive, fully-financed proposal to the Whitestone Board to acquire Whitestone for $15 per share in an all-cash transaction. Our

Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul

Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates.

Watching Madrigal Pharmaceuticals; Traders Circulate Unconfirmed Rumor From M&A Blog That The Co May Be Seeing Takeover Interest

Mergers and acquisitions are a large part of the business world, often impacting Wall Street. When companies merge or acquire, stock symbols change, valuations shift and investors must adjust their portfolios accordingly.

Types of Mergers & Acquisitions

Generally, businesses merge or complete an acquisition in a few basic ways.

Cash-for-Stock Acquisition

An acquisition involves a cash purchase of all that company’s stock, cashing out all its stockholders. In a situation such as this, the controlling company can either merge the 2 firms or operate the other business normally. In extreme cases, the controlling business may choose to sell off the pieces of an underperforming business, keeping the physical or intellectual properties it prefers to retain.

Stock-for-Stock Merger

If 2 companies merge, they combine assets, going “stock-for-stock,” either trading under 1 firm’s stock ticker or listing under a new ticker symbol.

IPO via Special Purpose Acquisition Company

Finally, a business that plans to go public may choose to merge with what is known as a special purpose acquisition company (SPAC). The new company is created to effect the merger, and a stock ticker symbol is assigned to the SPAC. For example, Lucid Motors merged with Churchill Capital Corp. IV (NYSE: CCIV) to effect a $4.4 billion IPO and list as (NYSE: LCID).

Check out Benzinga’s mergers & acquisitions calendar to learn when these deals are set to close across the marketplace.